Case File
efta-efta00916023DOJ Data Set 9OtherFrom: Jeffrey Epstein <[email protected]>
Date
Unknown
Source
DOJ Data Set 9
Reference
efta-efta00916023
Pages
1
Persons
0
Integrity
Extracted Text (OCR)
Text extracted via OCR from the original document. May contain errors from the scanning process.
From: Jeffrey Epstein <[email protected]>
To: desmond_shum(,'tS)
Subject:
Date: Thu, 21 Jul 2011 11:10:46 +0000
Rothschild travels to Beijing to raise $750m private equity
fund
21 Jul 2011. Source:
AltAssets
Chairman of RIT Capital Partners Lord Rothschild travelled to Beijing this week to work on a private
equity fund to raise renminbi in China and invest overseas.
According to the Financial Times, the J. Rothschild Creel Partners fund hopes to raise S750m from Chinese
investors by the end of the year.
The vehicle is one of the first of its kind to gain regulatory approval by Chinese authorities, given the country's
strict capital controls which make it difficult for companies and individuals to invest overseas.
According to the report, capital markets in China have slowly been opening up to allow outbound investment,
starting with equities and only recently allowing private equity funds.
The fund, which is a venture between RIT Capital, Chinese investment group the Creel Group and investment
advisory company Quercus Associates, is one of only two to have been approved so far.
It will target sectors including clean energy, pharmaceuticals and natural resources, amongst others.
-This unique venture will allow China's private sector to invest in Western companies, whilst providing
opportunities for Western companies to enter China's rapidly growing and vibrant economy," said Rothschild
when the fund was announced in March.
The information contained in this communication is
confidential, may be attorney-client privileged, may
constitute inside information, and is intended only for
the use of the addressee. It is the property of
Jeffrey Epstein
Unauthorized use, disclosure or copying of this
communication or any part thereof is strictly prohibited
and may be unlawful. If you have received this
communication in error, please notify us immediately by
return e-mail or by e-mail to jeevacation®gmail.com, and
destroy this communication and all copies thereof,
including all attachments. copyright -all rights reserved
EFTA00916023
Technical Artifacts (1)
View in Artifacts BrowserEmail addresses, URLs, phone numbers, and other technical indicators extracted from this document.
Email
[email protected]Related Documents (6)
DOJ Data Set 10OtherUnknown
EFTA01682184
186p
DOJ Data Set 10OtherUnknown
EFTA01370863
1p
Dept. of JusticeOtherUnknown
Medical Record/Clinical Encounter: DOJ-OGR-00026334
This clinical encounter document from the Bureau of Prisons details a medical evaluation of Jeffrey Epstein on July 12, 2019. It covers his medical history, current complaints, and treatment, including discussions around his triglyceride levels, sleep apnea, and back pain. The document was generated by the treating physician at the Metropolitan Correctional Center in New York.
1p
DOJ Data Set 8CorrespondenceUnknown
EFTA00014087
0p
DOJ Data Set 11OtherUnknown
EFTA02367961
1p
DOJ Data Set 10OtherUnknown
EFTA01977826
2p
Forum Discussions
This document was digitized, indexed, and cross-referenced with 1,400+ persons in the Epstein files. 100% free, ad-free, and independent.
Annotations powered by Hypothesis. Select any text on this page to annotate or highlight it.